DRUG
Price
$42.02
Change
-$1.93 (-4.39%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
313.46M
GNTA
Price
$3.50
Change
-$0.00 (-0.00%)
Updated
Sep 5, 04:15 PM (EDT)
Capitalization
64.01M
Interact to see
Advertisement

DRUG vs GNTA

Header iconDRUG vs GNTA Comparison
Open Charts DRUG vs GNTABanner chart's image
Bright Minds Biosciences
Price$42.02
Change-$1.93 (-4.39%)
Volume$500
Capitalization313.46M
Genenta Science SpA
Price$3.50
Change-$0.00 (-0.00%)
Volume$100
Capitalization64.01M
DRUG vs GNTA Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. GNTA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a Hold and GNTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DRUG: $43.95 vs. GNTA: $3.50)
Brand notoriety: DRUG and GNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 867% vs. GNTA: 49%
Market capitalization -- DRUG: $325.43M vs. GNTA: $64.01M
DRUG [@Biotechnology] is valued at $325.43M. GNTA’s [@Biotechnology] market capitalization is $64.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileGNTA’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • GNTA’s FA Score: 0 green, 5 red.
According to our system of comparison, DRUG is a better buy in the long-term than GNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 4 TA indicator(s) are bullish while GNTA’s TA Score has 5 bullish TA indicator(s).

  • DRUG’s TA Score: 4 bullish, 4 bearish.
  • GNTA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both DRUG and GNTA are a good buy in the short-term.

Price Growth

DRUG (@Biotechnology) experienced а +3.08% price change this week, while GNTA (@Biotechnology) price change was -7.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($313M) has a higher market cap than GNTA($64M). DRUG YTD gains are higher at: 22.016 vs. GNTA (-19.540).
DRUGGNTADRUG / GNTA
Capitalization313M64M489%
EBITDA-8.94MN/A-
Gain YTD22.016-19.540-113%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash51.4MN/A-
Total Debt141KN/A-
TECHNICAL ANALYSIS
Technical Analysis
DRUGGNTA
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZEOOF9.35N/A
N/A
Zeon Corp.
ACSYF0.80N/A
N/A
Accsys Technologies Plc.
TKCOF62.01N/A
N/A
Toho Co., Ltd.
BACRP248.00N/A
N/A
Bank of America Corp.
EMAUF0.16-0.01
-4.46%
EMPEROR METALS INC.

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with WVE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
+1.57%
WVE - DRUG
44%
Loosely correlated
+2.25%
PHMMF - DRUG
44%
Loosely correlated
N/A
IVA - DRUG
43%
Loosely correlated
-2.95%
TVGN - DRUG
32%
Poorly correlated
-1.20%
ATYR - DRUG
31%
Poorly correlated
-4.20%
More

GNTA and

Correlation & Price change

A.I.dvisor tells us that GNTA and WVE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNTA and WVE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
-1.96%
WVE - GNTA
30%
Poorly correlated
+2.25%
DRUG - GNTA
28%
Poorly correlated
+1.57%
BEIGF - GNTA
28%
Poorly correlated
N/A
PTHS - GNTA
25%
Poorly correlated
+16.87%
RLFTF - GNTA
24%
Poorly correlated
-1.06%
More